Display options
Cite
Brufsky A. . Exp Hematol Oncol. 2017;6:7doi: 10.1186/s40164-017-0066-5.
Brufsky, A. (2017). . Experimental hematology & oncology, 67. https://doi.org/10.1186/s40164-017-0066-5
Brufsky, Adam. "." Experimental hematology & oncology vol. 6 (2017): 7. doi: https://doi.org/10.1186/s40164-017-0066-5
Brufsky A. . Exp Hematol Oncol. 2017 Mar 22;6:7. doi: 10.1186/s40164-017-0066-5. eCollection 2017. PMID: 28344858; PMCID: PMC5361712.
Copy Download .nbib Format: NLM
Share it on

Exp Hematol Oncol. 2017 Mar 22;6:7. doi: 10.1186/s40164-017-0066-5. eCollection 2017.

[No title available]

Experimental hematology & oncology

Adam Brufsky

Affiliations

  1. Division of Hematology/Oncology, University of Pittsburgh, 300 Halket Street, Suite 4628, Pittsburgh, PA 15213 USA.

PMID: 28344858 PMCID: PMC5361712 DOI: 10.1186/s40164-017-0066-5

[No abstract available.]

Keywords: Breast cancer; Immunotherapy; Pathological complete response; nab-Paclitaxel

References

  1. Drug Des Devel Ther. 2015 Apr 15;9:2189-99 - PubMed
  2. Clin Breast Cancer. 2015 Apr;15(2):110-6 - PubMed
  3. Clin Cancer Res. 2002 May;8(5):1038-44 - PubMed
  4. Cancer Immunol Res. 2015 Apr;3(4):399-411 - PubMed
  5. Int J Nanomedicine. 2015 Mar 11;10:1969-75 - PubMed
  6. J Nucl Med. 2015 Jan;56(1):31-7 - PubMed
  7. Clin Breast Cancer. 2015 Jun;15(3):191-6 - PubMed
  8. J Clin Oncol. 2005 Nov 1;23(31):7794-803 - PubMed
  9. Trials. 2013 Aug 19;14:261 - PubMed
  10. Cancer. 2015 Oct 15;121(20):3639-48 - PubMed
  11. Am Soc Clin Oncol Educ Book. 2015;:e41-8 - PubMed
  12. Curr Oncol. 2013 Feb;20(1):24-9 - PubMed
  13. J Clin Pharmacol. 2014 Oct;54(10):1097-107 - PubMed
  14. Clin Cancer Res. 2008 Jul 1;14(13):4200-5 - PubMed
  15. BMC Cancer. 2015 Dec 29;15:1019 - PubMed
  16. BMC Cancer. 2014 May 08;14:326 - PubMed
  17. Clinicoecon Outcomes Res. 2013 Apr 11;5:125-35 - PubMed
  18. Anticancer Res. 2013 Aug;33(8):3407-13 - PubMed
  19. Clin Breast Cancer. 2013 Dec;13(6):416-20 - PubMed
  20. Trials. 2015 Dec 16;16:575 - PubMed
  21. Jpn J Clin Oncol. 2015 Jul;45(7):642-9 - PubMed
  22. J Clin Oncol. 2015 Jul 20;33(21):2361-9 - PubMed
  23. Clin Cancer Res. 2015 Jun 15;21(12):2722-9 - PubMed
  24. Clinicoecon Outcomes Res. 2015 May 12;7:249-56 - PubMed
  25. Lancet Oncol. 2016 Mar;17(3):345-56 - PubMed
  26. Int J Cancer. 2016 Feb 1;138(3):747-57 - PubMed
  27. Breast Cancer Res Treat. 2016 Feb;156(1):125-34 - PubMed
  28. Oncoimmunology. 2013 Dec 1;2(12):e26937 - PubMed
  29. Annu Rev Immunol. 2013;31:51-72 - PubMed
  30. Clin Breast Cancer. 2014 Aug;14(4):228-34 - PubMed
  31. Int J Nanomedicine. 2014 Mar 19;9:1443-52 - PubMed
  32. Clin Breast Cancer. 2015 Feb;15(1):31-6 - PubMed
  33. Clin Pharmacokinet. 2003;42(7):665-85 - PubMed
  34. Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):381-91 - PubMed
  35. Curr Oncol. 2013 Apr;20(2):97-103 - PubMed
  36. Clin Cancer Res. 2006 Feb 15;12(4):1317-24 - PubMed

Publication Types